To date, the most potent mucosal vaccine adjuvants to be identified have be
en bacterial toxins. The present data demonstrate that the type 2 ribosome-
inactivating protein (type 2 RIP), mistletoe lectin I (ML-I) is a strong mu
cosal adjuvant of plant origin. A number of plant lectins were investigated
as intranasal (i.n.) coadjuvants for a bystander protein, ovalbumin (OVA).
As a positive control, a potent mucosal adjuvant, cholera toxin (CT), was
used. Go-administration of ML-I or CT with OVA stimulated high titres of OV
A-specific serum immunoglobulin G (IgG) in addition to OVA specific IgA in
mucosal secretions. CT and ML-I were also strongly immunogenic, inducing hi
gh titres of specific serum IgG and specific IgA at mucosal sites. None of
the other plant lectins investigated significantly boosted the response to
co-administered OVA. Immunization with phytohaemagglutinin (PHA) plus OVA e
licited a lectin-specific response but did not stimulate an enhanced respon
se to OVA compared with the antigen alone. Intranasal delivery of tomato le
ctin (LEA) elicited a strong lectin-specific systemic and mucosal antibody
response but only weakly potentiated the response to co-delivered OVA. In c
ontrast, administration of wheatgerm agglutinin (WGA) or Ulex europaeus lec
tin 1 (UEA-I) with OVA stimulated a serum IgG response to OVA while the lec
tin-specific responses (particularly for WGA) were relatively low. Thus, th
ere was not a direct correlation between immunogenicity and adjuvanticity a
lthough the strongest adjuvants (CT. ML-I) were also highly immunogenic.